Pressure-Controlled Intermittent Coronary Sinus Occlusion: A Novel Approach to Improve Microvascular Flow and Reduce...

Area of Science:

• Cardiology
• Interventional Cardiology
• Biomedical Engineering

Background:

• Primary percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI) often results in suboptimal myocardial salvage.
• Microvascular dysfunction post-PCI is a significant contributor to adverse outcomes in STEMI patients, including heart failure and mortality.

Purpose of the Study:

• To evaluate the safety and effectiveness of Pressure-controlled intermittent Coronary Sinus Occlusion (PiCSO) in mitigating microvascular dysfunction during primary PCI for STEMI.
• To assess the impact of PiCSO on infarct size and microvascular perfusion in STEMI patients.

Main Methods:

• Non-randomized studies have explored PiCSO use during primary PCI.
• Ongoing randomized trials are investigating PiCSO in high-risk anterior STEMI patients undergoing primary PCI.

Main Results:

• Preliminary non-randomized data suggest PiCSO is safe and improves microvascular perfusion.
• Initial findings indicate that PiCSO may reduce infarct size in STEMI patients.

Conclusions:

• PiCSO is a promising technology for improving outcomes in STEMI patients undergoing primary PCI.
• Further randomized trials are necessary to confirm the benefits of PiCSO in reducing infarct size and preventing heart failure in STEMI.